Salicylic Acid Wart Patch for Common and Plantar Warts
salicylic acid wart patches
DNA Virus Infections+7
+ Infections
+ Skin Diseases
Treatment Study
Summary
Study start date: May 19, 2025
Actual date on which the first participant was enrolled.Common and plantar warts are skin growths caused by the human papilloma virus (HPV), affecting both adults and children. Although warts are generally harmless, they can cause pain and discomfort, especially plantar warts. Treating warts is important not only to alleviate these symptoms but also to prevent the virus from spreading. This study focuses on evaluating salicylic acid wart patches, which are designed to treat common and plantar warts in individuals over six years old. The patches aim to reduce wart size and prevent new warts by using salicylic acid to exfoliate the affected skin. Participants in the study will use patches containing 40% salicylic acid, which helps remove the outer layer of skin where the wart is located. The patches also contain lanolin to soften the skin. Researchers will measure the effectiveness by checking for changes in wart size using a dermatoscope, observing the appearance of new warts, and monitoring any side effects. Participants will also give feedback on the visibility of the warts and how easy the patches are to use. This study aims to confirm the safety and effectiveness of these patches in treating warts, offering an alternative to other treatments such as cryotherapy or surgical removal.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.30 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 6 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Inclusion Criteria: * giving consent to participate in the clinical trial (consent of the minor's guardian where applicable); * presence of at least 1 wart (common/plantar) on the body, with a lesion up to 1 cm in diameter; * age, at least 6 years. Exclusion Criteria: * failure to meet at least 1 inclusion criterion; * the patient has a known hypersensitivity to salicylic acid, salicylates or any other component of the patch; * patients with renal impairment (renal failure); * patients with skin conditions (e.g. inflammation, wounds, eczema) at the site of application, * patients concurrently using other topical treatments in the area of the wart, * diabetic patients.
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location